Identification of bis-quindolines as new antiinfective agents

Bioorganic and Medicinal Chemistry

Volumn 13, Issue 12, 2005, Pages 3955-3963

  Mardenborough, Leroy G ^a   Zhu, Xue Y ^a   Fan, Pincheng ^a   Jacob, Melissa R ^b   Khan, Shabana I ^b   Walker, Larry A ^b   Ablordeppey, Seth Y ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Antifungal; Antiinfective; Antimalarial; Antiparasitic; Cryptolepine; Indole bis quindolines; Indoloquinoline; Quaternary amines; Quindoline

Indexed keywords

1 METHYL 2 PHENYLQUINOLINIUM IODIDE; 1,4 BIS(10 INDOLO[3,2 B]QUINOLIN 5 IUM)BUTANE DIIODIDE; 1,5 BIS(10 INDOLO[3,2 B]QUINOLIN 5 IUM)PENTANE DIIODIDE; 1,5 BIS(INDOLO[3,2 B]QUINDOLIN 10 IUM)PENTANE DIIODIDE; 1,5 BIS(INDOLO[3,2 B]QUINDOLIN 10 YL)PENTANE; 10 (5 PHENYLPENTYL)QUINDOLINE; 10 METHYLQUINDOLINE; 2 BROMO 10 CYCLOHEXYLPENTYLQUINDOLINE; 2 BROMO 10 METHYLQUINDOLINE; 2 CYANO 10 CYCLOHEXYLPENTYLQUINDOLINE; 2 FLUORO 10 CYCLOHEXYLPENTYLQUINDOLINE; 2 METHOXY 10 CYCLOHEXYLPENTYLQUINDOLINE; 2 METHYL 10 CYCLOHEXYLPENTYLQUINDOLINE; 2 THIOPHENYL 10 CYCLOHEXYLPENTYLQUINDOLINE; 5 CYCLOHEXYLPENTYLPYRIDINIUM BROMIDE; 5 CYCLOHEXYLPENTYLQUINOLINIUM BROMIDE; 5 METHYL 10 (5 PHENYLPENTYL)QUINDOLINIUM IODIDE; ALKYL GROUP; AMPHOTERICIN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; ARTEMISININ; CHLOROQUINE; CIPROFLOXACIN; CRYPTOLEPINE; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL CELL; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; CELL DEATH; INHIBITORY CONCENTRATION 50; MITOSPORIC FUNGI; PLASMODIUM FALCIPARUM; QUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 19444373270     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2005.04.008     Document Type: Article

References (39)

1. D. Dwuma-Badu, J.S. Ayim, N.I. Fiagbe, J.E. Knapp, P.L. Schiff Jr., and D.J. Slatkin J. Pharm. Sci. 67 1978 433 434
2. S.Y. Ablordeppey, C.D. Hufford, R.F. Borne, and D. Dwuma-Badu Planta Med. 56 1990 416
3. K. Cimanga, T. De Bruyne, A. Lasure, B. Van Poel, L. Pieters, M. Claeys, D. Vanden Berghe, K. Kambu, L. Tona, and A.J. Vlietinck Planta Med. 62 1996 22 27
4. S.Y. Ablordeppey, P. Fan, J.H. Ablordeppey, and L. Mardenborough Curr. Med. Chem. 6 1999 1151 1195
5. A.O. Oyekan, and S.Y. Ablordeppey Gen. Pharmacol. 24 1993 1285 1290
6. A.O. Oyekan, and S.Y. Ablordeppey Gen. Pharmacol. 24 1993 461 469
7. M. Singh, M.P. Singh, and S. Ablordeppey Drug Dev. Ind. Pharm. 22 1996 377 381
8. B.K. Noamesi, and S.O.A. Bamgbose Planta Med. 39 1980 51 56
9. D.E. Bierer, D.M. Fort, C.D. Mendez, J. Luo, P.A. Imbach, L.G. Dubenko, S.D. Jolad, R.E. Gerber, J. Litvak, Q. Lu, P. Zhang, M.J. Reed, N. Waldeck, R.C. Bruening, B.K. Noamesi, R.F. Hector, T.J. Carlson, and S.R. King J. Med. Chem. 41 1998 894 901
10. K. Boakye-Yiadom, and S.M. Heman-Ackah J. Pharm. Sci. 68 1979 1510 1514
11. I.K. Sawer, M.I. Berry, M.W. Brown, and J.L. Ford J. Appl. Bacteriol. 79 1995 314 321
12. L. Dassonneville, A. Lansiaux, A. Wattelet, N. Wattez, C. Mahieu, S. Van Miert, L. Pieters, and C. Bailly Eur. J. Pharmacol. 409 2000 9 18
13. K. Cimanga, T. De Bruyne, L. Pieters, A.J. Vlietinck, and C.A. Turger J. Nat. Prod. 60 1997 688 691
14. C.W. Wright, J.D. Phillipson, S.O. Awe, G.C. Kirby, D.C. Warhurst, J. Quetin-Leclercq, and L. Angenot Phytother. Res. 10 1996 361 363
15. P. Grellier, L. Ramiaramanana, V. Millerioux, E. Deharo, J. Schrevel, F. Frappier, F. Trigalo, B. Bodo, and J.-L. Pousset Phytother. Res. 10 1996 317 332
16. G.C. Kirby, A. Paine, D.C. Warhurst, B.K. Noamesi, and J.D. Phillipson Phytother. Res. 9 1995 359 363
17. J.N. Lisgarten, J. Pous, M. Coll, C.W. Wright, and J. Aymami Acta Crystallogr. D Biol. Crystallogr. D 58 2002 312 313
18. L. Dassonneville, K. Bonjean, M.-C. De Pauw-Gillet, P. Colson, C. Houssier, J. Quetin-Leclercq, L. Angenot, and C. Bailly Biochemistry 38 1999 7719 7726
19. C. Bailly, W. Laine, B. Baldeyrou, M.-C. De Pauw-Gillet, P. Colson, C. Houssier, K. Cimanga, S. Van Miert, A.J. Vlietinck, and L. Pieters Anticancer Drug Des. 15 2000 191 201
20. K. Bonjean, M.-C. De Pauw-Gillet, P. Defresne, P. Colson, C. Houssier, L. Dassonneville, C. Bailly, R. Greimers, C. Wright, J. Quetin-Leclercq, M. Tits, and L. Angenot Biochemistry 37 1998 5146 5236
21. B. Guyen, C.M. Schultes, P. Hazel, J. Mann, and S. Neidle Org. Biomol. Chem. 2 2004 981 988
22. S.Y. Ablordeppey, P. Fan, A.M. Clark, and A. Nimrod Bioorg. Med. Chem. 7 1999 343 349
23. L.G. Mardenborough, P.C. Fan, S.Y. Ablordeppey, A. Nimrod, and A.M. Clark Med. Chem. Res. 9 1999 118 132
24. A.O. Oyekan, and S.Y. Ablordeppey Med. Chem. Res. 6 1996 602 610
25. S.Y. Ablordeppey, P. Fan, S. Li, A.M. Clark, and C.D. Hufford Bioorg. Med. Chem. 10 2002 1337 1346
26. S.J. Holt, and V. Petrow J. Chem. Soc. 1947 607 611
27. P. Fan, and S.Y. Ablordeppey J. Heterocycl. Chem. 34 1997 1789 1794
28. S. Radl, P. Konvicka, and P. Vachal J. Heterocycl. Chem. 37 2000 855 862
29. S.-W. Yang, M. Abdel-Kader, S. Malone, M.C.M. Werkhoven, J.H. Wisse, I. Bursuker, K. Neddermann, C. Fairchild, C. Raventos-Suarez, A.T. Menendez, K. Lane, and D.G.I. Kingston J. Nat. Prod. 62 1999 976 983
30. D.E. Bierer, L.G. Dubenko, P. Zhang, Q. Lu, P.A. Imbach, A.W. Garofalo, P.-W. Phuan, D.M. Fort, J. Litvak, R.E. Gerber, B. Sloan, J. Luo, R. Cooper, and G.M. Reaven J. Med. Chem. 41 1998 2754 2764
31. J.J. Chen, L.W. Deady, J. Desneves, A.J. Kaye, G.J. Finlay, B.C. Baguley, and W.A. Denny Bioorg. Med. Chem. 8 2000 2461 2466
32. M.M. Cooper, J.M. Lovell, and J.A. Joule Tetrahedron Lett. 37 1996 4283 4286
33. M. Guoyi, S. Khan, M.R. Jacob, B.L. Tekwani, Z. Li, D.S. Pasco, L.A. Walker, and I.A. Khan Antimicrob. Agents Chemother. 48 2004 4450 4452
34. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A5. National Committee for Clinical Laboratory Standards, Wayne, PA, 2000
35. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA, 1997
36. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes, 2nd ed. Tentative standard M24-T2. National Committee for Clinical Laboratory Standards, Wayne, PA, 2000
37. S.G. Franzblau, R.S. Witzig, J.C. McLaughlin, P. Torres, G. Madico, A. Hernandez, M.T. Degnan, M.B. Cook, V.K. Quenzer, R.M. Ferguson, and R.H. Gilman J. Clin. Microbiol. 36 1998 362 366
38. I. Muhammad, E. Bedir, S.I. Khan, B.L. Tekwani, I.A. Khan, S. Takamatsu, J. Pelletier, and L.A. Walker J. Nat. Prod. 67 2004 772 777
39. I. Muhammad, D.C. Dunbar, S.I. Khan, B.L. Tekwani, E. Bedir, S. Takamatsu, D. Ferreira, and L.A. Walker J. Nat. Prod. 66 2003 962 967